Lifecore Biomedical Inc. (LFCR) - Total Liabilities
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has total liabilities worth $204.72 Million USD as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Lifecore Biomedical Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Lifecore Biomedical Inc. - Total Liabilities Trend (1996–2026)
This chart illustrates how Lifecore Biomedical Inc.'s total liabilities have evolved over time, based on quarterly financial data. See Lifecore Biomedical Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Lifecore Biomedical Inc. Competitors by Total Liabilities
The table below lists competitors of Lifecore Biomedical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
|
USA | $6.81 Million |
|
Bank Artha Graha Internasional
JK:INPC
|
Indonesia | Rp28.83 Trillion |
|
Kafrit
TA:KAFR
|
Israel | ILA616.98 Million |
|
Seshasayee Paper and Boards Limited
NSE:SESHAPAPER
|
India | Rs4.71 Billion |
|
Associated Alcohols & Breweries Ltd.
NSE:ASALCBR
|
India | Rs1.61 Billion |
|
InfuSystems Holdings Inc
NYSE MKT:INFU
|
USA | $39.91 Million |
|
Elektrotim SA
WAR:ELT
|
Poland | zł160.44 Million |
|
Astral Resources NL
AU:AAR
|
Australia | AU$4.92 Million |
Liability Composition Analysis (1996–2026)
This chart breaks down Lifecore Biomedical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LFCR market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecore Biomedical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecore Biomedical Inc. (1996–2026)
The table below shows the annual total liabilities of Lifecore Biomedical Inc. from 1996 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-05-31 | $246.38 Million | +3.52% |
| 2025-05-31 | $238.01 Million | -1.91% |
| 2024-05-31 | $242.65 Million | +29.84% |
| 2023-05-31 | $186.88 Million | -0.18% |
| 2022-05-31 | $187.22 Million | -37.62% |
| 2021-05-31 | $300.14 Million | -3.26% |
| 2020-05-31 | $310.27 Million | +24.63% |
| 2019-05-31 | $248.95 Million | +63.63% |
| 2018-05-31 | $152.14 Million | +17.16% |
| 2017-05-31 | $129.86 Million | -0.96% |
| 2016-05-31 | $131.12 Million | +3.77% |
| 2015-05-31 | $126.36 Million | +16.07% |
| 2014-05-31 | $108.86 Million | -1.51% |
| 2013-05-31 | $110.53 Million | -12.37% |
| 2012-05-31 | $126.13 Million | +83.91% |
| 2011-05-31 | $68.59 Million | +1.28% |
| 2010-05-31 | $67.72 Million | +163.82% |
| 2009-05-31 | $25.67 Million | -25.75% |
| 2008-05-31 | $34.57 Million | +18.02% |
| 2007-05-31 | $29.30 Million | -9.04% |
| 2006-05-31 | $32.20 Million | +21.30% |
| 2005-05-31 | $26.55 Million | -11.23% |
| 2004-05-31 | $29.91 Million | -20.40% |
| 2003-05-31 | $37.57 Million | -25.25% |
| 2002-05-31 | $50.26 Million | -27.42% |
| 2001-05-31 | $69.25 Million | +3.77% |
| 2000-05-31 | $66.73 Million | +649.82% |
| 1999-05-31 | $8.90 Million | +2.30% |
| 1998-05-31 | $8.70 Million | -40.41% |
| 1997-05-31 | $14.60 Million | +711.11% |
| 1996-05-31 | $1.80 Million | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more